• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

GSK3787

CAS No. 188591-46-0

GSK3787 ( GSK3787 | GSK-3787 | GSK 3787 )

产品货号. M12948 CAS No. 188591-46-0

GSK3787 是一种选择性且不可逆的 PPARδ 拮抗剂,pIC50 为 6.6,对 hPPARα 或 hPPARγ 没有可测量的亲和力。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥405 有现货
10MG ¥640 有现货
25MG ¥1482 有现货
50MG ¥2633 有现货
100MG ¥4439 有现货
500MG ¥9477 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    GSK3787
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    GSK3787 是一种选择性且不可逆的 PPARδ 拮抗剂,pIC50 为 6.6,对 hPPARα 或 hPPARγ 没有可测量的亲和力。
  • 产品描述
    GSK3787 is as a selective and irreversible antagonist of PPARδ with pIC50 of 6.6, with no measurable affinity for hPPARα or hPPARγ.
  • 体外实验
    GSK3787 is identified as a potent and selective hPPARδ ligand (pIC50=6.6) with no measurable affinity for hPPARα or hPPARγ (pIC50 < 5) in our standard in vitro ligand displacement assay. GSK3787 is inactive against hPPARα and hPPARγ in similar functional antagonist assays. GSK3787 fails to activate the receptor in a standard hPPARδ-GAL4 chimera cell-based reporter assay. GSK3787 is a selective PPARδ antagonist with equipotent species activity against the human and mouse receptor.
  • 体内实验
    GSK3787 has pharmacokinetic properties suitable for use as an in vivo PPARδ antagonist tool compound in mice. GSK3787 is administered intravenously (0.5 mg/kg) and orally (10 mg/kg) to male C57BL/6 mice. Mean clearance (CL) and volume of distribution at steady state (Vss) following iv administration are 39±11 (mL/min)/kg and 1.7±0.4 L/kg, respectively. Following oral administration, good exposure (Cmax=881±166 ng/mL, AUCinf=3343±332 h?ng/mL), half-life (2.7±1.1 h), and bioavailability (F=77±17%) are observed. Oral administration of GSK3787 (10 mg/kg) leads to a serum Cmax of 2.2±0.4 μM in C57BL/6 male mice. Oral administration of GW0742 causes an increase in expression of Angptl4 and Adrp mRNA (known PPARβ/δ target genes) in wild-type mouse colon epithelium, and this effect is not found in Pparβ/δ-null mouse colon epithelium. Coadministration of GSK3787 with GW0742 effectively prevents the ligand-induced expression of both Angptl4 and Adrp mRNA in wild-type mouse colon epithelium, and this effect is not found in Pparβ/δ-null mouse colon epithelium. Oral administration of GSK3787 causes a modest increase in promoter occupancy of PPARβ/δ in the PPRE region of both the Angptl4 and Adrp genes, but coadministration of GSK3787 with GW0742 results in markedly less accumulation of PPARβ/δ in the PPRE region of both the Angptl4 and Adrp genes in wild-type mouse colon epithelium.
  • 同义词
    GSK3787 | GSK-3787 | GSK 3787
  • 通路
    Metabolic Enzyme/Protease
  • 靶点
    PPAR
  • 受体
    PPARδ
  • 研究领域
    Other Indications
  • 适应症
    ——

化学信息

  • CAS Number
    188591-46-0
  • 分子量
    392.78
  • 分子式
    C15H12ClF3N2O3S
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: 79 mg/mL (201.13 mM)
  • SMILES
    O=C(NCCS(=O)(C1=NC=C(C(F)(F)F)C=C1)=O)C2=CC=C(Cl)C=C2
  • 化学全称
    4-chloro-N-(2-((5-(trifluoromethyl)pyridin-2-yl)sulfonyl)ethyl)benzamide

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Shearer BG, et al. J Med Chem, 2010, 53(4), 1857-186
产品手册
关联产品
  • K-111

    K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.

  • MCC 555

    MCC 555 (Isaglitazone;Netoglitazone;RWJ 241947) 是 PPARγ 的激活配体,EC50 为 8 uM。

  • SR 16832

    SR 16832 是一种双位点 PPARγ 抑制剂。它还可以比正位共价拮抗剂 GW 9662 和 T 0070907 更有效地抑制内源配体的结合和 PPARγ 的转录活性。